Remove Blood Clot Remove Patient Care Remove Technology
article thumbnail

Osso VR Expands Cardiology Training through ACC Collaboration

DAIC

With the integration of Osso VR's immersive technology and the expertise of the ACC, interventionalists will gain access to a state-of-the-art training simulation of the workflow and skills required to successfully perform a left atrial appendage occlusion procedure (LAAO). and globally."

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.

article thumbnail

Avicenna.AI Secures FDA Clearance for Two Healthcare AI Solutions

DAIC

Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians. These achievements stand as a testament to the unwavering commitment of our team.”

Embolism 105
article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges. “Duo

Stent 105
article thumbnail

Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients

DAIC

milla1cf Wed, 02/28/2024 - 19:59 February 28, 2024 — Royal Philips , a global leader in health technology, announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system.

article thumbnail

Comprehending the Dreadful Impacts of COVID-19 on Cardiovascular Treatments

SoftCath

Do the healthcare clinics have the tools and technologies needed for diagnosing complicated heart conditions? Henceforth, numerous healthcare organizations are stepping forward in bringing a positive change and adopting the latest technologies such as cath lab reporting software, robotic machines for treatments, etc.

article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The label includes a “black box” warning for CV risk due to blood clots.